123 related articles for article (PubMed ID: 19122336)
21. Differential activities of CYP1A isozymes in hepatic and intestinal microsomes of control and 3-methylcholanthrene-induced rats.
Spatzenegger M; Horsmans Y; Verbeeck RK
Pharmacol Toxicol; 2000 Feb; 86(2):71-7. PubMed ID: 10728918
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the dose-response of CYP1B1, CYP1A1, and CYP1A2 in the liver of female Sprague-Dawley rats following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Walker NJ; Portier CJ; Lax SF; Crofts FG; Li Y; Lucier GW; Sutter TR
Toxicol Appl Pharmacol; 1999 Feb; 154(3):279-86. PubMed ID: 9931287
[TBL] [Abstract][Full Text] [Related]
23. Persistent expression of 3-methylcholanthrene-inducible cytochromes P4501A in rat hepatic and extrahepatic tissues.
Moorthy B
J Pharmacol Exp Ther; 2000 Jul; 294(1):313-22. PubMed ID: 10871328
[TBL] [Abstract][Full Text] [Related]
24. Differential regulation of expression of hepatic and pulmonary cytochrome P4501A enzymes by 3-methylcholanthrene in mice lacking the CYP1A2 gene.
Kondraganti SR; Jiang W; Moorthy B
J Pharmacol Exp Ther; 2002 Dec; 303(3):945-51. PubMed ID: 12438513
[TBL] [Abstract][Full Text] [Related]
25. Validation of precision-cut liver slices in dynamic organ culture as an in vitro model for studying CYP1A1 and CYP1A2 induction.
Drahushuk AT; McGarrigle BP; Tai HL; Kitareewan S; Goldstein JA; Olson JR
Toxicol Appl Pharmacol; 1996 Oct; 140(2):393-403. PubMed ID: 8887457
[TBL] [Abstract][Full Text] [Related]
26. Regulation of pulmonary and hepatic cytochrome P4501A expression in the rat by hyperoxia: implications for hyperoxic lung injury.
Couroucli XI; Welty SE; Geske RS; Moorthy B
Mol Pharmacol; 2002 Mar; 61(3):507-15. PubMed ID: 11854430
[TBL] [Abstract][Full Text] [Related]
27. Effect of polyunsaturated fatty acids ω-3 on the induction of activity and expression of CYP1A1 and CYP1A2 genes in the liver of rats under the influence of indole-3-carbinol.
Kravchenko LV; Tutel'yan VA; Trusov NV; Guseva GV; Aksenov IV
Bull Exp Biol Med; 2014 Jan; 156(3):327-31. PubMed ID: 24771368
[TBL] [Abstract][Full Text] [Related]
28. Differential time-course and dose-response relationships of TCDD-induced CYP1B1, CYP1A1, and CYP1A2 proteins in rats.
Santostefano MJ; Ross DG; Savas U; Jefcoate CR; Birnbaum LS
Biochem Biophys Res Commun; 1997 Apr; 233(1):20-4. PubMed ID: 9144388
[TBL] [Abstract][Full Text] [Related]
29. Arylhydrocarbon receptor-dependent induction of liver and lung cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic hydrocarbons and polychlorinated biphenyls in genetically engineered C57BL/6J mice.
Shimada T; Inoue K; Suzuki Y; Kawai T; Azuma E; Nakajima T; Shindo M; Kurose K; Sugie A; Yamagishi Y; Fujii-Kuriyama Y; Hashimoto M
Carcinogenesis; 2002 Jul; 23(7):1199-207. PubMed ID: 12117779
[TBL] [Abstract][Full Text] [Related]
30. Transcriptional induction of the cytochrome P4501A1 gene by a thiazolium compound, YH439.
Lee IJ; Jeong KS; Roberts BJ; Kallarakal AT; Fernandez-Salguero P; Gonzalez FJ; Song BJ
Mol Pharmacol; 1996 Jun; 49(6):980-8. PubMed ID: 8649358
[TBL] [Abstract][Full Text] [Related]
31. Effect of pyridine on the expression of cytochrome P450 isozymes in primary rat hepatocyte culture.
Wu D; Ramin SA; Cederbaum AI
Mol Cell Biochem; 1997 Aug; 173(1-2):103-11. PubMed ID: 9278260
[TBL] [Abstract][Full Text] [Related]
32. Induction of pulmonary CYP1A1 by nicotine.
Iba MM; Scholl H; Fung J; Thomas PE; Alam J
Xenobiotica; 1998 Sep; 28(9):827-43. PubMed ID: 9764926
[TBL] [Abstract][Full Text] [Related]
33. CYP1A1 and CYP1A2 expression: comparing 'humanized' mouse lines and wild-type mice; comparing human and mouse hepatoma-derived cell lines.
Uno S; Endo K; Ishida Y; Tateno C; Makishima M; Yoshizato K; Nebert DW
Toxicol Appl Pharmacol; 2009 May; 237(1):119-26. PubMed ID: 19285097
[TBL] [Abstract][Full Text] [Related]
34. Expression of CYP1A in liver of A/Sn and CC57BR mice differing in sensitivity to hepatocarcinogenesis induced by o-aminoazotoluene.
Timofeeva OA; Filipenko ML; Rychkova NA; Gulyaeva LF; Lyakhovich VV
Biochemistry (Mosc); 2000 Jun; 65(6):718-22. PubMed ID: 10887293
[TBL] [Abstract][Full Text] [Related]
35. Pharmacologic profiling of human and rat cytochrome P450 1A1 and 1A2 induction and competition.
Westerink WM; Stevenson JC; Schoonen WG
Arch Toxicol; 2008 Dec; 82(12):909-21. PubMed ID: 18493746
[TBL] [Abstract][Full Text] [Related]
36. The alkaloid rutaecarpine is a selective inhibitor of cytochrome P450 1A in mouse and human liver microsomes.
Ueng YF; Jan WC; Lin LC; Chen TL; Guengerich FP; Chen CF
Drug Metab Dispos; 2002 Mar; 30(3):349-53. PubMed ID: 11854157
[TBL] [Abstract][Full Text] [Related]
37. cDNA cloning and characterization of feline CYP1A1 and CYP1A2.
Tanaka N; Miyasho T; Shinkyo R; Sakaki T; Yokota H
Life Sci; 2006 Nov; 79(26):2463-73. PubMed ID: 17097115
[TBL] [Abstract][Full Text] [Related]
38. Molecular cloning and expression of two novel avian cytochrome P450 1A enzymes induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Gilday D; Gannon M; Yutzey K; Bader D; Rifkind AB
J Biol Chem; 1996 Dec; 271(51):33054-9. PubMed ID: 8955152
[TBL] [Abstract][Full Text] [Related]
39. Androgen-mediated down-regulation of CYP1A subfamily genes in the pig liver.
Kojima M; Sekimoto M; Degawa M
J Endocrinol; 2010 Nov; 207(2):203-11. PubMed ID: 20713500
[TBL] [Abstract][Full Text] [Related]
40. Differential inducing effect of benzo[a]pyrene on gene expression and enzyme activity of cytochromes P450 1A1 and 1A2 in Sprague-Dawley and Wistar rats.
Floreani M; Gabbia D; Barbierato M; DE Martin S; Palatini P
Drug Metab Pharmacokinet; 2012; 27(6):640-52. PubMed ID: 22785257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
